Orthofix International NV (OFIX.O)

OFIX.O

About

Orthofix International N.V. (Orthofix) is a diversified, global medical device company focused on developing and delivering repair and regenerative solutions to the spine and orthopedic markets. The Company operates in two global business units, which include Spine and Orthopedics. It designs, develops, manufactures, markets and... (more)

Buy/Sell

» Analyst Consensus

Overall

Beta:	0.98
Market Cap (Mil.):	$516.10
Shares Outstanding (Mil.):	19.45
Dividend:	--
Yield (%):	--

Financials

	OFIX.O	Industry	Sector
P/E (TTM):	11.10	30.63	35.83
EPS (TTM):	2.39	--	--
ROI:	9.58	10.42	18.72
ROE:	12.59	13.40	19.54

Latest News about OFIX.O

BRIEF-Orthofix concludes bone growth stimulator investigation

Dec 16 - Orthofix International NV : * Concludes bone growth stimulator investigation * It has resolved all matters related to the investigation of its bone growth

16 Dec 2012

» More OFIX.O News

Competitors

	Price	Change
Johnson & Johnson (JNJ.N)	$88.09	+0.64
Medtronic, Inc. (MDT.N)	$49.84	+0.20
Stryker Corporation (SYK.N)	$68.90	-0.16
Zimmer Holdings, Inc. (ZMH.N)	$80.34	-0.28
Smith & Nephew plc (SN.L)	777.00p	-6.50
Biomet, Inc. (BMET.OQ)	--	--
NuVasive, Inc. (NUVA.OQ)	$23.26	+0.33

Earnings vs. Estimates

Analyst Research Reports

Report Title	Price
ORTHOFIX INTL NV INC (OFIX) 12-months forecast Provider: Pechala's Reports	$15.00 Buy
Orthofix International NV: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. Provider: Reuters Investment Profile	$20.00 Buy
Thomson Reuters Stock Report - ORTHOFIX INTERNATIONAL NV (OFIX-O) Provider: Thomson Reuters Stock Report	$25.00 Buy
ValuEngine Detailed Valuation Report for OFIX Provider: ValuEngine, Inc.	$127.00 Buy
ORTHOFIX INTL (OFIX) Zacks Company Snapshot Provider: Zacks Investment Research Inc.	$12.00 Buy

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

» More Analyst Research

Related Topics:

Stocks
Stock Screener
Market Data
Healthcare
Medical Equipment / Supplies / Distribution

Edition:

U.S.
- Arabic
- Argentina
- Brazil
- Canada
- China
- France
- Germany
- India
- Italy
- Japan
- Latin America
- Mexico
- Russia
- Spain
- United Kingdom

Back to top

Reuters.com

Legal

Support & Contact

Connect with Reuters

About

Our Flagship financial information platform incorporating Reuters Insider

An ultra-low latency infrastructure for electronic trading and data distribution

A connected approach to governance, risk and compliance

Our next generation legal research platform

Our global tax workstation

Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.

NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.